Executive Management

Alan S. Krasner serves as Chief Endocrinologist and joined Crinetics as Chief Medical Officer in 2018. Prior to Crinetics, he was a Senior Medical Director at Shire Pharmaceuticals, where he served as global development lead for elagolix. Alan also previously worked at Biodel and Pfizer, where he conducted clinical research at various stages of development in diabetes and obesity. 

Alan holds a bachelor’s degree and master’s degree from Northwestern University, and received clinical training in internal medicine and endocrinology at Johns Hopkins University.